Skip to main content

Stratos Genomics Awarded Access to Microfabrication Lab to Develop Nanopore Sequencing Tech


This article was originally published on January 8, 2010.

Stratos Genomics, a Seattle-based biotech startup, has won access to a microfabrication laboratory run by the Washington Technology Center, an economic development organization, "to further its DNA sequencing product development," WTC said last week.

According to WTC, Stratos Genomics is developing a new DNA sequencing method "that will dramatically reduce the time and costs of high-throughput DNA sequencing."

The award will allow Stratos Genomics to access WTC's Seattle-based microfabrication facility for three months for a proposal entitled "Nanopore Noise Reduction Project." According to WTC, the project aims to meet a technical goal that is part of a proof of concept for Stratos' technology, which "creates, encodes, and measures surrogate molecules derived from DNA targets to produce DNA sequence information."

"Successful demonstration of the technology will open the door for company growth to address the next commercialization steps," according to WTC.

WTC made the award under a new technology stimulus program that grants small businesses in Washington access to its 15,000-square-foot microfabrication laboratory. The lab includes facilities and specialized equipment for microelectromechanical systems, or MEMS, research and product or process development.

According to its website, WTC helps companies develop and commercialize new products and technologies by channeling state, federal, and private resources.

Stratos Genomics, founded in 2008, is part of Stratos, which designs and develops products for a variety of companies, including Microsoft, Abbott Laboratories, Nike, and Spacelabs Medical.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.